Phase I Study of Tivantinib Plus Bevacizumab
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Tivantinib (Primary) ; Bevacizumab
- Indications Solid tumours
- Focus Adverse reactions
- 03 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jan 2013 New trial record
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.